- Home
- NKTR vs WRN Comparison
NKTR vs WRN Comparison
Compare NKTR & WRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NKTR | WRN |
|---|---|---|
| Founded | 1990 | 2006 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 609.2M |
| IPO Year | 1996 | 2006 |
Fundamental Metrics
Financial Performance| Metric | NKTR | WRN |
|---|---|---|
| Price | $68.53 | $2.41 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $146.67 | $4.58 |
| AVG Volume (30 Days) | 546.4K | ★ 1.0M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $307,711,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 86.00 | N/A |
| 52 Week Low | $33.40 | $1.78 |
| 52 Week High | $109.00 | $4.26 |
Technical Indicators
Market Signals| Indicator | NKTR | WRN |
|---|---|---|
| Relative Strength Index (RSI) | 42.22 | 49.87 |
| Support Level | $64.99 | $2.28 |
| Resistance Level | $76.63 | $2.61 |
| Average True Range (ATR) | 2.76 | 0.11 |
| MACD | -0.61 | -0.02 |
| Stochastic Oscillator | 21.41 | 49.35 |
Price Performance
Historical ComparisonAbout NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.
About WRN Western Copper and Gold Corporation
Western Copper & Gold Corp is a Canada-based exploration-stage company. The company is engaged in the exploration and development of the Casino mineral property located in Yukon, Canada (the Casino Project). The Casino can deliver the critical minerals necessary for the energy transition while serving as an engine for long-term economic growth and prosperity in the North.